GAIN THERAPEUTICS INC (GANX)
US36269B1052 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to GANX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 187.77% above the current price.
GANX was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about GANX.
In the previous month the buy percentage consensus was at a similar level.
GANX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | Maxim Group | Initiate | Buy |
| 2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-27 | Chardan Capital | Maintains | Buy |
| 2022-12-09 | Chardan Capital | Initiate | Buy |
| 2022-11-25 | Oppenheimer | Maintains | Outperform |
| 2022-11-14 | BTIG | Maintains | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-19 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2021-11-03 | B. Riley Securities | Initiate | Buy |
| 2021-04-12 | BTIG | Initiate | Buy |
| 2021-04-12 | Oppenheimer | Initiate | Outperform |